Exactmer
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2026-04-01attributed |
| Founded | unknown |
| Headquarters | 30+ |
| Industry | biotech |
| Stage | unknown |
| Website | exactmer.com |
Nanostar Sieving polymer-synthesis platform for oligonucleotide therapeutics, ADC linkers, and PEGs. Sold to pharma and biotech — Novartis, AstraZeneca, Alnylam — plus academic labs. 30+ qualified staff in London with custom synthesis and analytical capabilities.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-01 | grant | $2.7M | undisclosed |
Detected tech stack
Cloudflare, WordPress 7.0, PHP, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | exactmer.com, read 2026-05-02 |
| Description | self-reported | exactmer.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.